Evaluation of One Burr Hole Evacuation for Subdural Hematoma

NCT ID: NCT06119932

Last Updated: 2023-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the outcome of one burrhole evacuation for subdural hematoma and it has the same result of traditional two burrhole

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Subdural hematoma (SDH): abnormal Collection of Liquefied blood degradation underneath the dura matter (1.2.3).
* one of the most frequent types of intracranial haemorrhage, That is still associated with significant morbidity (1.4.5).
* The SDH: is a common disease in elderly Patient, and Its Incidence is highest in persons older than 70 Years of age (1.5).
* Types of Subdural hematoma(18.19)

1- Acute: present within 48-72 hours of injury. 2. Sub-acute: manifest itself between 3-20 day. 3- Chronic (CH): produce symptoms from 3 weeks to several months after injury Risk Factors: (7.8.9.10.11.12)
1. Trauma; mostly minor Trauma, Approximately two thirds of The Patients have suffered one. Reports exist of chronic SDH due to birth trauma in neonates.
2. Advanced age: The elderly are at risk due to:

1. brain atrophy, whereby The bridging veins are stretched and become more fragile.
2. Older People tend to fall more often and Suffer minor head trauma.
3. With increase age, The incidence of blood Thinner administration raises leading to increased risk for haemorrhage
3. Chronic alcoholism:
4. Gender: men, from all age groups, suffer higher rates of chsDH than woman.
5. CoagulaPathy: Therapeutic anticoagulation and antiplatelet therapy.
6. Medical Conditions: sepsis, hepatic failure, hemophilia, DIC and renal dialysis.
7. Intracranial hypotension: as after ventriculoperitoneal shunt. clinical presentation (1.13)
* Symptoms of increase intra cranial pressure: Headache, Nausea, vomiting.
* Focal neurological deficit - (weakness, aphasia).
* Disturbed conscious level (DCL)
* Seizures
* Imaging investigation:

CT brain (14.15)

* Management : (1.6.16.17)

1. Conservative: A watch, wait and re-scan Policy is usually recommended in asymptomatic or minimally symptomatic patient with a thin CHSDH.
2. Surgical: For symptomatic (SDH) a- burr hole drainage B-twist drill drainage c- craniotomy
* prognostic factors : (2.5) 1- age of patient 2- Associated chronic diseases like hypertension, liver diseases …….Etc 3- Laboratory investigation like Hb , platlate count ,pc,and PT. 5- Hematoma thickness 6- number of burr hole : one or two burr hole

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subdural Hematoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evacuation for subdural hematoma by one burrhole

Evacuation for subdural hematoma by one burrhole

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with subdural hematoma either unilateral or bilateral
* fit for surgery
* Chronic SDH
* Subacute SDH
* Age: patients older than 18 years old
* SEX: Both sex

Exclusion Criteria

* Patients unfit for surgery
* Acute SDH
* subdural hyroma
* subdural empyema
* patient treated conservatively
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammed lotfi abdelkareem

Neurosurgical resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shady Hassaan

Role: STUDY_DIRECTOR

Lecturer of Neurosurgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mohammed lotfi abdelkareem

Minya, Malawi, Egypt

Site Status

Mohammed lotfi abdelkareem

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohammed Lotfi, Resident

Role: CONTACT

01147341661

Ahmed Abo kresha, Professor

Role: CONTACT

+201006814906

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohammed Lotfi a, Reseddnt

Role: primary

Mohammed Lotfi

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Subdural hematoma

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Outcomes of Uterine Rupture
NCT02878226 COMPLETED